Marine Pharmacology
A section of Marine Drugs (ISSN 1660-3397).
Section Information
Considering that oceans cover approximately 70% of our planet, there are huge untapped marine resources available for the discovery of future therapeutic applications. For example, several marine drugs have been shown to affect basically all hallmarks of cancer and even to contribute to epigenetic reprogramming, although selected cell signaling pathways remain to be further investigated.
This Section of Marine Drugs aims to provide a comprehensive and advanced publication platform for studies concerning all aspects of marine pharmacology, including approved marine-drug-related reports, the pharmacological characterization of marine compounds or their derivatives, preclinical and clinical pharmacological studies on marine-derived compounds, and the development of marine-derived drugs as well as marine-derived pharmaceutical formulations.
Scope
- Discovery and development of marine-derived drugs
- Marine-derived drug leads
- Preclinical research on marine-derived drugs
- Clinical research on marine-derived drugs
- Reports of approved marine-derived drugs
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Marine-Derived Compounds Applied in Cardiovascular Disease (Deadline: 30 April 2024)
- Therapeutic Potential of Marine Polyphenols (Deadline: 30 April 2024)
- Metabolic and Neurologic Diseases and Marine Natural Products (Deadline: 30 April 2024)
- Bioactive Metabolites from Marine-Derived Penicillium or Aspergillus Species (Deadline: 15 May 2024)
- Marine Natural Products with Anti-aging Activity (Deadline: 31 May 2024)
- Marine Drugs Research in Spain 2nd Edition (Deadline: 30 June 2024)
- Bioactive Compounds from Natural Immune Systems of Marine Invertebrates (Deadline: 30 June 2024)
- Microalgae and Age-Related Diseases: New Innovative Approaches to Age-Old Problems (Deadline: 30 June 2024)
- Recent Advances in Marine-Derived Pigments (Deadline: 30 June 2024)
- Marine Anti-biofilm Compounds from Natural to Synthetic Compounds (Deadline: 30 June 2024)
- Pharmacological Potential of Marine Natural Products (Deadline: 30 June 2024)
- Marine Natural Products as Potential Drug Leads (Deadline: 30 June 2024)
- Discovery of Marine-Derived Anticancer Agents (Deadline: 31 July 2024)
- Marine Natural Products and Signaling Pathways (Deadline: 31 July 2024)
- Polysaccharides from Marine Environment (Deadline: 31 July 2024)
- Bio-Active Components from Marine Sponges (Deadline: 31 August 2024)
- Antioxidant and Anticancer Activities of Compounds Isolated from Seagrasses and Seaweeds (Deadline: 31 August 2024)
- Marine Drug Discovery through Molecular Docking (Deadline: 30 September 2024)
- Bio-Active Products from Mangrove Ecosystems 2.0 (Deadline: 30 September 2024)
- Marine-Derived Bioactive Substances and Their Mechanisms of Action (Deadline: 30 September 2024)
- Marine Anti-inflammatory and Antioxidant Agents 4.0 (Deadline: 30 September 2024)
- Zebrafish Models in Marine Drug Discovery (Deadline: 31 October 2024)
- Marine Natural Products as Anticancer Agents 4.0 (Deadline: 31 October 2024)
- Target Identification of Marine Natural Products (Deadline: 31 October 2024)
- Application of Marine Nature Products to Reduce Oxidative Stress (Deadline: 31 October 2024)
- From Seaside to Bedside: Dedicated to Professor José María Fernández Sousa-Faro (Deadline: 31 October 2024)
- Marine Drug Development and Pre-clinical Studies for Infection and Inflammation (Deadline: 31 December 2024)
Topical Collection
Following topical collection within this section is currently open for submissions:
